More on Semaglutide in Early Type 1 Diabetes
N Engl J Med
.
2024 Jan 18;390(3):291.
doi: 10.1056/NEJMc2311608.
Authors
Larry A Weinrauch
1
,
John A D'Elia
2
Affiliations
1
Harvard Medical School, Boston, MA lweinrauch@hms.harvard.edu.
2
Joslin Diabetes Center, Boston, MA.
PMID:
38231641
DOI:
10.1056/NEJMc2311608
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 1* / drug therapy
Glucagon-Like Peptides / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use
Substances
semaglutide
Glucagon-Like Peptides
Hypoglycemic Agents